about
Obstetrical antiphospholipid syndrome: from the pathogenesis to the clinical and therapeutic implicationsPathophysiology of thrombosis and pregnancy morbidity in the antiphospholipid syndrome.Treatment of refractory obstetric antiphospholipid syndrome: the state of the art and new trends in the therapeutic management.Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6.Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies.Pregnancy, lupus and antiphospholipid syndrome (Hughes syndrome).Pregnancy and thrombophilia.Complement activation and pregnancy failure.Top 10 clinical research developments in antiphospholipid syndrome.Autoantibody response and pregnancy-related pathology induced by combined LPS and tetanus toxoid hyperimmunization in BALB/c and C57BL/6 mice.Expression of chemokine decoy receptors and their ligands at the porcine maternal-fetal interface.Role of molecular mimicry and polyclonal cell activation in the induction of pathogenic β2-glycoprotein I-directed immune response in Balb/c mice upon hyperimmunization with tetanus toxoid.Sixth meeting of the European Forum on antiphospholipid antibodies. How to improve the understanding of the antiphospholipid syndrome?Autoantibodies to plasminogen and tissue plasminogen activator in women with recurrent pregnancy loss.Maternal and fetal outcome in women with antiphospholipid syndrome: a three-year observational study.An increased risk for non allo-immunization related intrauterine fetal death in RhD-negative patients.Anti-beta-2 glycoprotein I antibodies affect Bcl-2 and Bax trophoblast expression without evidence of apoptosis.
P2860
Q26998188-D8029151-6208-4397-879A-C115A54BA257Q34287356-1B4823BF-ADEF-41CF-A695-40A9F2BB7244Q34476952-449F3471-CDCE-409B-ACD5-496FDC787F33Q35844573-2D0EEAB6-CCFD-4D53-B56F-273F66D93A4FQ35977256-97E989B0-D0C3-4C02-A293-F333B3D89559Q36458150-E5C8FC7C-3AE2-4E40-8E42-F6E30482135CQ36867306-D7EF704A-2F0C-4410-A6A1-D8C8DD108DD4Q37638376-C6B502C8-9B4C-419F-B04E-BFD3935FCE0CQ38135335-82B89634-280E-4EBB-9437-B381305D2023Q41645294-5BD011C5-B4D2-41EC-A929-D5F652B55370Q44777105-55FEA47F-6882-4867-9658-9BA8D14C681EQ44952838-6509E0C5-F18E-455D-9186-30AEA6567E01Q53203652-29EC6A97-FD95-4448-9B1B-BB64A3C4B057Q53560316-DE3B716C-0422-4511-A46E-B0CB6F87F33BQ53773313-4158B687-7C74-4F86-A9F0-CFCC6566CD8FQ54518799-C11143B0-2180-4427-A8C2-692296F60081Q54591463-B9043A3C-3596-4052-BFD8-2900221D3F3A
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Antiphospholipid antibodies as cause of pregnancy loss.
@ast
Antiphospholipid antibodies as cause of pregnancy loss.
@en
type
label
Antiphospholipid antibodies as cause of pregnancy loss.
@ast
Antiphospholipid antibodies as cause of pregnancy loss.
@en
prefLabel
Antiphospholipid antibodies as cause of pregnancy loss.
@ast
Antiphospholipid antibodies as cause of pregnancy loss.
@en
P2093
P2860
P1433
P1476
Antiphospholipid antibodies as cause of pregnancy loss
@en
P2093
P2860
P304
P356
10.1191/0961203304LU2001OA
P577
2004-01-01T00:00:00Z